Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GNPX Genprex, Inc.

休市中 05-17 16:00:00 EDT

2.55

+0.13

+5.37%

盘后2.45

-0.10-3.92%

19:04 EDT

最高2.58	最低2.43	成交量2.45万
今开2.49	昨收2.42	日振幅6.20%
总市值535.17万	流通市值526.93万	总股本209.87万
成交额6.19万	换手率1.19%	流通股本206.64万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":2.55,"timestamp":1715976000000,"preClose":2.42,"halted":0,"volume":24490,"hourTrading":{"tag":"盘后","latestPrice":2.45,"preClose":2.55,"latestTime":"19:04 EDT","volume":2333,"amount":5717.18,"timestamp":1715987077604},"delay":0,"floatShares":2066399,"shares":2098698,"eps":-22.562988,"marketStatus":"休市中","marketStatusCode":7,"change":0.13,"latestTime":"05-17 16:00:00 EDT","open":2.485,"high":2.58,"low":2.43,"amount":61859.224877,"amplitude":0.061983,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-22.562988,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1522296000000,"adjPreClose":2.42,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.42,"preClose":2.45,"latestTime":"09:24 EDT","volume":181,"amount":447.26001379999997,"timestamp":1715952246163},"postHourTrading":{"tag":"盘后","latestPrice":2.45,"preClose":2.55,"latestTime":"19:04 EDT","volume":2333,"amount":5717.18,"timestamp":1715987077604},"volumeRatio":0.3888955122124743},"requestUrl":"/m/hq/s/GNPX/wiki","defaultTab":"wiki","newsList":[{"id":"2435903654","title":"HC Wainwright & Co.：重申Genprex(GNPX.US)评级，由买入调整至买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435903654","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435903654?lang=zh_cn&edition=full","pubTime":"2024-05-15 23:34","pubTimestamp":1715787288,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Genprex(GNPX.US)评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152334518b0bb259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405152334518b0bb259&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435519662","title":"Genprex, Inc.盘中异动 股价大跌7.11%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435519662?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:43","pubTimestamp":1715694230,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时43分，Genprex, Inc.股票出现异动，股价急速跳水7.11%。截至发稿，该股报2.22美元/股，成交量8524股，换手率0.41%，振幅3.35%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514214350861ed1a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514214350861ed1a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435614375","title":"Genprex, Inc.盘中异动 早盘股价大涨9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435614375","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435614375?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:54","pubTimestamp":1715608441,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时54分，Genprex, Inc.股票出现波动，股价急速拉升9.47%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215401876275a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513215401876275a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434852231","title":"Genprex, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434852231","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434852231?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:14","pubTimestamp":1715350462,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时14分，Genprex, Inc.股票出现波动，股价大幅下跌5.35%。截至发稿，该股报2.30美元/股，成交量7144股，换手率0.34%，振幅8.85%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510221423861ec72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510221423861ec72b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433097785","title":"Genprex, Inc.盘中异动 早盘股价大跌6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433097785","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433097785?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:04","pubTimestamp":1715090651,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时04分，Genprex, Inc.股票出现波动，股价急速下挫6.27%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722041287e8620b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722041287e8620b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433401132","title":"Genprex, Inc.盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433401132","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433401132?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:00","pubTimestamp":1715011203,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日00时00分，Genprex, Inc.股票出现异动，股价大幅上涨5.32%。截至发稿，该股报2.57美元/股，成交量2.5758万股，换手率1.23%，振幅9.02%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700000387e85ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700000387e85ddf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432093577","title":"Genprex, Inc.盘中异动 快速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432093577","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432093577?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:55","pubTimestamp":1714672514,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日01时55分，Genprex, Inc.股票出现波动，股价急速上涨5.31%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030155147925b541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030155147925b541&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431432594","title":"Genprex, Inc.盘中异动 早盘股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431432594","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431432594?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:34","pubTimestamp":1714484077,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时34分，Genprex, Inc.股票出现异动，股价快速拉升7.21%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021343879258570&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021343879258570&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430168277","title":"Genprex, Inc.盘中异动 早盘大幅上涨5.72%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430168277","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430168277?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:34","pubTimestamp":1714138477,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时34分，Genprex, Inc.股票出现异动，股价大幅上涨5.72%。截至发稿，该股报2.24美元/股，成交量1046股，换手率0.05%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Tevogen Bio Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为596.71%、71.34%、22.87%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为35.87%、34.80%、24.13%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262134387a563941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262134387a563941&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429145907","title":"Genprex, Inc.盘中异动 下午盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429145907","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429145907?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:53","pubTimestamp":1713894811,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时53分，Genprex, Inc.股票出现异动，股价快速拉升5.41%。截至发稿，该股报2.28美元/股，成交量1.4835万股，换手率0.78%，振幅5.55%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为1.73%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042401533187e82e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042401533187e82e4a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428654442","title":"Genprex, Inc.盘中异动 早盘快速上涨9.27%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428654442","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428654442?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:30","pubTimestamp":1713533458,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时30分，Genprex, Inc.股票出现波动，股价快速拉升9.27%。截至发稿，该股报2.43美元/股，成交量1548股，换手率0.08%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Portage Biotech Inc.、Chromocell Therapeutics Corporation涨幅较大，Bio-Path Holdings, Inc.、Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为86.09%、3.35%、2.76%，振幅较大的相关个股有Vigil Neuroscience, Inc.、Genprex, Inc.、Portage Biotech Inc.，振幅分别为9.45%、8.79%、8.58%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213058861e772a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213058861e772a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427882022","title":"Genprex, Inc.盘中异动 股价大跌7.65%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427882022","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427882022?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:17","pubTimestamp":1713205020,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时17分，Genprex, Inc.股票出现波动，股价快速下跌7.65%。截至发稿，该股报2.48美元/股，成交量1.7847万股，换手率0.93%，振幅7.84%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1538.04%、1226.90%、860.52%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、114.53%、80.04%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160217017920a693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160217017920a693&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426413293","title":"Genprex, Inc.盘中异动 早盘快速下挫5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426413293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426413293?lang=zh_cn&edition=full","pubTime":"2024-04-10 22:26","pubTimestamp":1712759207,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日22时26分，Genprex, Inc.股票出现波动，股价快速下挫5.54%。截至发稿，该股报2.90美元/股，成交量4616股，换手率0.24%，振幅1.63%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Aim Immunotech Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1620.74%、73.86%、31.39%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts 、Calidi Biotherapeutics, Inc.，振幅分别为72.57%、33.63%、31.96%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041022264887e7f50f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041022264887e7f50f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425833591","title":"Genprex, Inc.盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425833591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425833591?lang=zh_cn&edition=full","pubTime":"2024-04-06 01:19","pubTimestamp":1712337569,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日01时19分，Genprex, Inc.股票出现异动，股价大幅上涨5.33%。截至发稿，该股报3.15美元/股，成交量9393股，换手率0.49%，振幅5.64%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406011929791edc2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406011929791edc2e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424184613","title":"Genprex, Inc.盘中异动 早盘股价大涨7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424184613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424184613?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:32","pubTimestamp":1712151124,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时32分，Genprex, Inc.股票出现异动，股价大幅上涨7.39%。截至发稿，该股报3.05美元/股，成交量3952股，换手率0.21%，振幅5.63%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为233.11%、67.52%、16.06%，振幅较大的相关个股有Kintara Therapeutics, Inc.、Virios Therapeutics, Inc.、居里，振幅分别为21.31%、9.13%、9.09%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403213204791ebf02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403213204791ebf02&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423841157","title":"Genprex Inc   预计每股亏损3.93美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2423841157","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2423841157?lang=zh_cn&edition=full","pubTime":"2024-03-30 03:07","pubTimestamp":1711739233,"startTime":"0","endTime":"0","summary":"   * Genprex Inc    预计在3月31日发布业绩报告时，季度营收将保持不变。*    * LSEG 的分析师平均预计 Genprex Inc 每股亏损 3.93 美元。* 华尔街对 Genprex Inc 的 12 个月目标价中位数为 165.00 美元，高于其上次收盘价 2.98 美元。3月29日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422615367","title":"Genprex, Inc.盘中异动 早盘快速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422615367","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422615367?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:36","pubTimestamp":1711460201,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时36分，Genprex, Inc.股票出现波动，股价急速下跌5.17%。截至发稿，该股报2.85美元/股，成交量6876股，换手率0.36%，振幅3.83%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Stoke Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Abvc Biopharma, Inc.涨幅较大，Abvc Biopharma, Inc.、Stoke Therapeutics, Inc.、Xtl生物制药较为活跃，换手率分别为110.92%、15.12%、12.38%，振幅较大的相关个股有Stoke Therapeutics, Inc.、Bio-Path Holdings, Inc.、Molecular Templates, Inc.，振幅分别为24.77%、15.08%、14.64%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262136417a4f345c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262136417a4f345c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422482335","title":"Genprex, Inc.盘中异动 快速拉升6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422482335","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422482335?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:43","pubTimestamp":1711374228,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时43分，Genprex, Inc.股票出现异动，股价大幅上涨6.86%。截至发稿，该股报3.27美元/股，成交量8394股，换手率0.44%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1644.31%、54.50%、31.58%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Sagimet Biosciences Inc. - Series A，振幅分别为36.42%、19.84%、14.63%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521434887e7b7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521434887e7b7ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420164725","title":"Genprex, Inc.股价重挫11.24% 市值跌10.42万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420164725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420164725?lang=zh_cn&edition=full","pubTime":"2024-03-20 22:07","pubTimestamp":1710943653,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日22时07分，Genprex, Inc.股票出现波动，股价急速跳水11.24%。截至发稿，该股报3.00美元/股，成交量1.3351万股，换手率0.90%，振幅2.92%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd.、Taysha Gene Therapies, Inc.涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Nls Pharmaceutics Ltd.较为活跃，换手率分别为57.40%、36.00%、26.42%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、Jaguar Health, Inc.、Taysha Gene Therapies, Inc.，振幅分别为33.82%、30.62%、25.16%。Genprex, Inc.公司简介：Genprex Inc 是一家临床阶段的基因治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202207337a4dfa5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202207337a4dfa5a&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":0.0991},{"period":"1month","weight":0.1538},{"period":"3month","weight":-0.4205},{"period":"6month","weight":-0.7423},{"period":"1year","weight":-0.9161},{"period":"ytd","weight":-0.7228}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司，为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司，开发一种新的方法来治疗癌症，根据其新的专利技术平台，包括其最初的候选产品，Oncoprex免疫基因治疗提供，或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因，然后静脉内施用并被肿瘤细胞摄取，其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制，其中断细胞信号通路，其引起癌细胞的复制和增殖，重新建立癌细胞中凋亡途径或程序性细胞死亡途径，并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.912357},{"month":2,"riseRate":0.5,"avgChangeRate":0.15537},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.179543},{"month":4,"riseRate":0.285714,"avgChangeRate":0.230015},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.007973},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.075945},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.174388},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032905},{"month":9,"riseRate":0,"avgChangeRate":-0.143387},{"month":10,"riseRate":0,"avgChangeRate":-0.215282},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.138223},{"month":12,"riseRate":0.5,"avgChangeRate":0.020272}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}